These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6608988)

  • 1. Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocyte clone for murine malignant gliomas.
    Yamasaki T; Handa H; Yamashita J; Watanabe Y; Namba Y; Hanaoka M
    Cancer Res; 1984 May; 44(5):1776-83. PubMed ID: 6608988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental approach to specific adoptive immunotherapy for malignant brain tumors.
    Yamasaki T; Kikuchi H
    Nihon Geka Hokan; 1989 Nov; 58(6):485-92. PubMed ID: 2519184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.
    Yamasaki T; Handa H; Yamashita J; Watanabe Y; Namba Y; Hanaoka M
    Neurosurg Rev; 1984; 7(1):37-54. PubMed ID: 6611523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
    Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse gamma-interferon complementary DNA.
    Nishihara K; Miyatake S; Sakata T; Yamashita J; Kikuchi H; Kawade Y; Zu Y; Namba Y; Hanaoka M; Watanabe Y
    Cancer Res; 1988 Sep; 48(17):4730-5. PubMed ID: 3136912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.
    Plautz GE; Touhalisky JE; Shu S
    Cell Immunol; 1997 Jun; 178(2):101-7. PubMed ID: 9225000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
    Yamasaki T; Yamashita J; Handa H; Namda Y; Hanaoka M
    No Shinkei Geka; 1983 Oct; 11(10):1059-67. PubMed ID: 6196674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
    Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory effects of interleukin 2 and interferon on syngeneic murine malignant glioma-specific cytotoxic T-lymphocytes.
    Yamasaki T; Kikuchi H; Yamashita J; Handa H; Kuwata S; Taguchi M; Namba Y; Hanaoka M
    Cancer Res; 1988 Jun; 48(11):2981-7. PubMed ID: 3259157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.
    Keyaki A; Kuribayashi K; Sakaguchi S; Masuda T; Yamashita J; Handa H; Nakayama E
    Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tumor-specific Th2 clone initiating tumor rejection via primed CD8+ cytotoxic T-lymphocyte activation in mice.
    Shen Y; Fujimoto S
    Cancer Res; 1996 Nov; 56(21):5005-11. PubMed ID: 8895757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of experimental malignant glioma-specific cytotoxic T lymphocyte clone by T cell growth factor.
    Yamasaki T; Handa H; Yamashita J; Namba Y; Watanabe Y; Kuwata S; Hanaoka M
    J Neurosurg; 1984 May; 60(5):998-1004. PubMed ID: 6201598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
    Inoue M; Plautz GE; Shu S
    Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppressor mechanism in tumor immunology: characteristics of suppressor T-cells in glioma-bearing mice].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1983 Jul; 35(7):703-9. PubMed ID: 6194806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory role in gamma interferon production by a T cell growth factor-dependent experimental malignant glioma-specific cytotoxic T lymphocyte clone.
    Yamasaki T; Handa H; Yamashita J; Watanabe Y; Taguchi M; Kuwata S; Namba Y; Hanaoka M
    J Neurosurg; 1985 Nov; 63(5):763-70. PubMed ID: 3932609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
    Kim JA; Averbook BJ; Chambers K; Rothchild K; Kjaergaard J; Papay R; Shu S
    Cancer Res; 2001 Mar; 61(5):2031-7. PubMed ID: 11280763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.